About CYTOO
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
Founded in 2008 by François Chatelain.
- Founded
- 2008
- Employees
- 11 to 50
- Total funding
- $16.2M
- Headquarters
- Grenoble
Leadership
The top of CYTOO's org chart, with how many people report into each leader.
Erwann Ventre
Chief Operating Officer
6 reports
Joanne Young
Director R&d
4 reports
Alice Gutjahr
Director Of Partnerships
Jobs at CYTOO
No open positions right now. Explore more companies on TheJobsMap.